# Pharma \& Medtech Webinars \| GMP Webinars \& Training Courses: Driving Quality \& Excellence in GMP\| GDP \| GLP With Engaging Digital Content

> Join Qualistery for expert\-led life science webinars and content on the latest trends in regulated fields: Pharma, Biotech, MedTech\.

Generated by Yoast SEO v28.8, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Life Sciences: Pharma, Medtech \& Biotech Webinars \- Homepage](https://qualistery.com/)
- [Pharma Webinars — Free Live \& On‑Demand Training for GxP Professionals](https://qualistery.com/pharma-webinars-free-live-on‑demand-training-for-gxp-professionals/)
- [Free GMP Webinars](https://qualistery.com/gmp-training-online-live-courses/)
- [Explore Webinar Opportunities](https://qualistery.com/explore-webinar-opportunities/)
- [Live GMP Webinars](https://qualistery.com/live-webinars/)

## Posts
- [Supply‑Chain Complexity Meets Innovation in NTC’s Latest Glaucoma Portfolio Acquisition](https://qualistery.com/supply-chain-complexity-meets-innovation-in-ntcs-latest-glaucoma-portfolio-acquisition/): NTC’s latest glaucoma acquisition brings a clear opportunity, but it also raises challenges for quality and manufacturing teams at NTC, which they tackle with a year long expertise\. Chronic eye\-drop therapies, especially preservative\-free products, depend on strong aseptic control, reliable packaging, qualified suppliers, and consistent product knowledge which the NTC team is well equipped with\. 

- [What Cannabinoid APIs Are Teaching CMC Teams About Quality by Design](https://qualistery.com/what-cannabinoid-apis-are-teaching-cmc-teams-about-quality-by-design/): Physicochemical behavior in an active pharmaceutical ingredient is never purely a formulation\-development topic\. It has direct consequences for specifications, analytical methods, process understanding, stability programs, and the evidence a regulator will eventually expect to see\.
- [Digital Guardrails: EMA’s Ban on GenAI and the Death of the Paper Leaflet](https://qualistery.com/digital-guardrails-emas-ban-on-genai-and-the-death-of-the-paper-leaflet/): The ground under pharmaceutical manufacturing just shifted\. From the FDA’s new "15\-day" enforcement of 483 responses to the EMA’s definitive line in the sand regarding AI in the cleanroom, we are witnessing a full\-scale regulatory renovation\. In the premiere episode of \*The Golden Batch\*, we break down why executive accountability is no longer optional, how $2 billion "megasites" are reshaping the global supply chain, and why the era of the paper patient leaflet is officially coming to an end\. 

If you're in the C\-suite, the Quality office, or managing the line, this is the ground\-truth you need to stay \*\*In Spec\*\* in 2026\.
- [Unlocking Unmet Medical Needs with Full‑Service Partnerships: Insights from NTC Pharma](https://qualistery.com/unlocking-unmet-medical-needs-with-full‑service-partnerships-insights-from-ntc-pharma/): At CPHI Frankfurt 2025, Andrea Boccardi, the Head of Business Franchise at NTC Pharma reveals how NTC has helped their pharma and MedTech clients to  by taking preemptive measures to navigate future regulatory challenges\. 
- [Driving AI\-Ready GxP Manufacturing: Key Takeaways from Aizon](https://qualistery.com/driving-ai-ready-gxp-manufacturing-key-takeaways-from-aizon/): At CPHI Frankfurt 2025, Geri Studebaker, Chief Commercial Officer at Aizon, sheds light
 into the real\-world challenges and next\-step solutions for AI\-driven pharmaceutical manufacturing\.

## Optional
- [Sitemap index](https://qualistery.com/sitemap_index.xml)